New pancreatic cancer drug cuts death risk by 60% in trial Pancreatic cancer pill daraxonrasib showed a 60% lower death risk vs chemotherapy in trial data, prompting a 41.4% share jump. 14 Apr 2026 #PancreaticCancer#Oncology#Daraxonrasib#ClinicalTrial#RevolutionMedicines
